Dr. Alicia Morgans: Putting Chemo Into Perspective
This interview, “Dr. Alicia Morgans: Putting Chemo Into Perspective,” is provided by...
Read MoreSelect Page
Posted by Alicia K. Morgans, MD, MPH | Aug 2019
This interview, “Dr. Alicia Morgans: Putting Chemo Into Perspective,” is provided by...
Read MorePosted by Scott Eggener, MD | May 2019
Scott Eggener, MD, reviews the findings from a phase II international, multi-institutional trial evaluating a new minimally-invasive technology for prostate tissue ablation. He covers the primary safety and efficacy endpoints of the trial, as well as future directions for this technology.
Read MorePosted by Maha H. Hussain, MD, FACP, FASCO | Mar 2018
Dr. Maha H.A. Hussain, MBChB, reviews the PROSPER trial, which tested the efficacy and safety of enzalutamide in the setting of nonmetastatic CRPC. Following her summary, she and Dr. E. David Crawford, MD, engage in a question and answer session.
Read MorePosted by Scott Eggener, MD | Apr 2017
Dr. Scott Eggener presented “MRI Guided Biopsy and Ablation” at the 27th annual...
Read More